The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Eszopiclone Drug Market Research Report 2025
Synopsis
Eszopiclone, marketed by Sunovion under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia.
The global Eszopiclone Drug market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 115 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Eszopiclone Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eszopiclone Drug.
Report Scope
The Eszopiclone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eszopiclone Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eszopiclone Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sunovion
Teva
Dr. Reddy's Laboratories
Sun Pharmaceutical
Glenmark Pharmaceuticals
Aurobindo Pharma
Lupin Pharmaceuticals
Mylan
West Ward Pharmaceuticals
McKesson Medical-Surgical
Segment by Type
1 mg Tablets
2 mg Tablets
3 mg Tablets
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eszopiclone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eszopiclone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Eszopiclone, marketed by Sunovion under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia.
The global Eszopiclone Drug market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 115 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Eszopiclone Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eszopiclone Drug.
Report Scope
The Eszopiclone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eszopiclone Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eszopiclone Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sunovion
Teva
Dr. Reddy's Laboratories
Sun Pharmaceutical
Glenmark Pharmaceuticals
Aurobindo Pharma
Lupin Pharmaceuticals
Mylan
West Ward Pharmaceuticals
McKesson Medical-Surgical
Segment by Type
1 mg Tablets
2 mg Tablets
3 mg Tablets
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eszopiclone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eszopiclone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Eszopiclone Drug Market Overview
1.1 Product Overview and Scope of Eszopiclone Drug
1.2 Eszopiclone Drug Segment by Type
1.2.1 Global Eszopiclone Drug Market Value Comparison by Type (2024-2030)
1.2.2 1 mg Tablets
1.2.3 2 mg Tablets
1.2.4 3 mg Tablets
1.3 Eszopiclone Drug Segment by Application
1.3.1 Global Eszopiclone Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Eszopiclone Drug Market Size Estimates and Forecasts
1.4.1 Global Eszopiclone Drug Revenue 2019-2030
1.4.2 Global Eszopiclone Drug Sales 2019-2030
1.4.3 Global Eszopiclone Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eszopiclone Drug Market Competition by Manufacturers
2.1 Global Eszopiclone Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eszopiclone Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eszopiclone Drug Average Price by Manufacturers (2019-2024)
2.4 Global Eszopiclone Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eszopiclone Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eszopiclone Drug, Product Type & Application
2.7 Eszopiclone Drug Market Competitive Situation and Trends
2.7.1 Eszopiclone Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Eszopiclone Drug Players Market Share by Revenue
2.7.3 Global Eszopiclone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Eszopiclone Drug Retrospective Market Scenario by Region
3.1 Global Eszopiclone Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eszopiclone Drug Global Eszopiclone Drug Sales by Region: 2019-2030
3.2.1 Global Eszopiclone Drug Sales by Region: 2019-2024
3.2.2 Global Eszopiclone Drug Sales by Region: 2025-2030
3.3 Global Eszopiclone Drug Global Eszopiclone Drug Revenue by Region: 2019-2030
3.3.1 Global Eszopiclone Drug Revenue by Region: 2019-2024
3.3.2 Global Eszopiclone Drug Revenue by Region: 2025-2030
3.4 North America Eszopiclone Drug Market Facts & Figures by Country
3.4.1 North America Eszopiclone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eszopiclone Drug Sales by Country (2019-2030)
3.4.3 North America Eszopiclone Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Eszopiclone Drug Market Facts & Figures by Country
3.5.1 Europe Eszopiclone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eszopiclone Drug Sales by Country (2019-2030)
3.5.3 Europe Eszopiclone Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eszopiclone Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Eszopiclone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eszopiclone Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Eszopiclone Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Eszopiclone Drug Market Facts & Figures by Country
3.7.1 Latin America Eszopiclone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eszopiclone Drug Sales by Country (2019-2030)
3.7.3 Latin America Eszopiclone Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eszopiclone Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Eszopiclone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eszopiclone Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eszopiclone Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Eszopiclone Drug Sales by Type (2019-2030)
4.1.1 Global Eszopiclone Drug Sales by Type (2019-2024)
4.1.2 Global Eszopiclone Drug Sales by Type (2025-2030)
4.1.3 Global Eszopiclone Drug Sales Market Share by Type (2019-2030)
4.2 Global Eszopiclone Drug Revenue by Type (2019-2030)
4.2.1 Global Eszopiclone Drug Revenue by Type (2019-2024)
4.2.2 Global Eszopiclone Drug Revenue by Type (2025-2030)
4.2.3 Global Eszopiclone Drug Revenue Market Share by Type (2019-2030)
4.3 Global Eszopiclone Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eszopiclone Drug Sales by Application (2019-2030)
5.1.1 Global Eszopiclone Drug Sales by Application (2019-2024)
5.1.2 Global Eszopiclone Drug Sales by Application (2025-2030)
5.1.3 Global Eszopiclone Drug Sales Market Share by Application (2019-2030)
5.2 Global Eszopiclone Drug Revenue by Application (2019-2030)
5.2.1 Global Eszopiclone Drug Revenue by Application (2019-2024)
5.2.2 Global Eszopiclone Drug Revenue by Application (2025-2030)
5.2.3 Global Eszopiclone Drug Revenue Market Share by Application (2019-2030)
5.3 Global Eszopiclone Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sunovion
6.1.1 Sunovion Corporation Information
6.1.2 Sunovion Description and Business Overview
6.1.3 Sunovion Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sunovion Eszopiclone Drug Product Portfolio
6.1.5 Sunovion Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Eszopiclone Drug Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Eszopiclone Drug Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Eszopiclone Drug Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Corporation Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Glenmark Pharmaceuticals Eszopiclone Drug Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aurobindo Pharma Eszopiclone Drug Product Portfolio
6.6.5 Aurobindo Pharma Recent Developments/Updates
6.7 Lupin Pharmaceuticals
6.6.1 Lupin Pharmaceuticals Corporation Information
6.6.2 Lupin Pharmaceuticals Description and Business Overview
6.6.3 Lupin Pharmaceuticals Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lupin Pharmaceuticals Eszopiclone Drug Product Portfolio
6.7.5 Lupin Pharmaceuticals Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Eszopiclone Drug Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 West Ward Pharmaceuticals
6.9.1 West Ward Pharmaceuticals Corporation Information
6.9.2 West Ward Pharmaceuticals Description and Business Overview
6.9.3 West Ward Pharmaceuticals Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 West Ward Pharmaceuticals Eszopiclone Drug Product Portfolio
6.9.5 West Ward Pharmaceuticals Recent Developments/Updates
6.10 McKesson Medical-Surgical
6.10.1 McKesson Medical-Surgical Corporation Information
6.10.2 McKesson Medical-Surgical Description and Business Overview
6.10.3 McKesson Medical-Surgical Eszopiclone Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 McKesson Medical-Surgical Eszopiclone Drug Product Portfolio
6.10.5 McKesson Medical-Surgical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eszopiclone Drug Industry Chain Analysis
7.2 Eszopiclone Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eszopiclone Drug Production Mode & Process
7.4 Eszopiclone Drug Sales and Marketing
7.4.1 Eszopiclone Drug Sales Channels
7.4.2 Eszopiclone Drug Distributors
7.5 Eszopiclone Drug Customers
8 Eszopiclone Drug Market Dynamics
8.1 Eszopiclone Drug Industry Trends
8.2 Eszopiclone Drug Market Drivers
8.3 Eszopiclone Drug Market Challenges
8.4 Eszopiclone Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Eszopiclone Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Eszopiclone Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Eszopiclone Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Eszopiclone Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Eszopiclone Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Eszopiclone Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Eszopiclone Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Eszopiclone Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Eszopiclone Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Eszopiclone Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Eszopiclone Drug, Product Type & Application
Table 12. Global Key Manufacturers of Eszopiclone Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Eszopiclone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eszopiclone Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Eszopiclone Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Eszopiclone Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Eszopiclone Drug Sales Market Share by Region (2019-2024)
Table 19. Global Eszopiclone Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Eszopiclone Drug Sales Market Share by Region (2025-2030)
Table 21. Global Eszopiclone Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Eszopiclone Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Eszopiclone Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Eszopiclone Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Eszopiclone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Eszopiclone Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Eszopiclone Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Eszopiclone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Eszopiclone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Eszopiclone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Eszopiclone Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Eszopiclone Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Eszopiclone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Eszopiclone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Eszopiclone Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Eszopiclone Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Eszopiclone Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Eszopiclone Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Eszopiclone Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Eszopiclone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Eszopiclone Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Eszopiclone Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Eszopiclone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Eszopiclone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Eszopiclone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Eszopiclone Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Eszopiclone Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Eszopiclone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Eszopiclone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Eszopiclone Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Eszopiclone Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Eszopiclone Drug Sales Market Share by Type (2019-2024)
Table 53. Global Eszopiclone Drug Sales Market Share by Type (2025-2030)
Table 54. Global Eszopiclone Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Eszopiclone Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Eszopiclone Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Eszopiclone Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Eszopiclone Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Eszopiclone Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Eszopiclone Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Eszopiclone Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Eszopiclone Drug Sales Market Share by Application (2019-2024)
Table 63. Global Eszopiclone Drug Sales Market Share by Application (2025-2030)
Table 64. Global Eszopiclone Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Eszopiclone Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Eszopiclone Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Eszopiclone Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Eszopiclone Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Eszopiclone Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Sunovion Corporation Information
Table 71. Sunovion Description and Business Overview
Table 72. Sunovion Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Sunovion Eszopiclone Drug Product
Table 74. Sunovion Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Eszopiclone Drug Product
Table 79. Teva Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Corporation Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Dr. Reddy's Laboratories Eszopiclone Drug Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Sun Pharmaceutical Corporation Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sun Pharmaceutical Eszopiclone Drug Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Glenmark Pharmaceuticals Corporation Information
Table 91. Glenmark Pharmaceuticals Description and Business Overview
Table 92. Glenmark Pharmaceuticals Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Glenmark Pharmaceuticals Eszopiclone Drug Product
Table 94. Glenmark Pharmaceuticals Recent Developments/Updates
Table 95. Aurobindo Pharma Corporation Information
Table 96. Aurobindo Pharma Description and Business Overview
Table 97. Aurobindo Pharma Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Aurobindo Pharma Eszopiclone Drug Product
Table 99. Aurobindo Pharma Recent Developments/Updates
Table 100. Lupin Pharmaceuticals Corporation Information
Table 101. Lupin Pharmaceuticals Description and Business Overview
Table 102. Lupin Pharmaceuticals Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Lupin Pharmaceuticals Eszopiclone Drug Product
Table 104. Lupin Pharmaceuticals Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Mylan Eszopiclone Drug Product
Table 109. Mylan Recent Developments/Updates
Table 110. West Ward Pharmaceuticals Corporation Information
Table 111. West Ward Pharmaceuticals Description and Business Overview
Table 112. West Ward Pharmaceuticals Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. West Ward Pharmaceuticals Eszopiclone Drug Product
Table 114. West Ward Pharmaceuticals Recent Developments/Updates
Table 115. McKesson Medical-Surgical Corporation Information
Table 116. McKesson Medical-Surgical Description and Business Overview
Table 117. McKesson Medical-Surgical Eszopiclone Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. McKesson Medical-Surgical Eszopiclone Drug Product
Table 119. McKesson Medical-Surgical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Eszopiclone Drug Distributors List
Table 123. Eszopiclone Drug Customers List
Table 124. Eszopiclone Drug Market Trends
Table 125. Eszopiclone Drug Market Drivers
Table 126. Eszopiclone Drug Market Challenges
Table 127. Eszopiclone Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Eszopiclone Drug
Figure 2. Global Eszopiclone Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Eszopiclone Drug Market Share by Type in 2023 & 2030
Figure 4. 1 mg Tablets Product Picture
Figure 5. 2 mg Tablets Product Picture
Figure 6. 3 mg Tablets Product Picture
Figure 7. Global Eszopiclone Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Eszopiclone Drug Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Drug store
Figure 11. Global Eszopiclone Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Eszopiclone Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Eszopiclone Drug Sales (2019-2030) & (K Units)
Figure 14. Global Eszopiclone Drug Average Price (USD/Unit) & (2019-2030)
Figure 15. Eszopiclone Drug Report Years Considered
Figure 16. Eszopiclone Drug Sales Share by Manufacturers in 2023
Figure 17. Global Eszopiclone Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Eszopiclone Drug Players: Market Share by Revenue in 2023
Figure 19. Eszopiclone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Eszopiclone Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Eszopiclone Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Eszopiclone Drug Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Eszopiclone Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Eszopiclone Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Eszopiclone Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Eszopiclone Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Eszopiclone Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Eszopiclone Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Eszopiclone Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Eszopiclone Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Eszopiclone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Eszopiclone Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Eszopiclone Drug by Type (2019-2030)
Figure 56. Global Eszopiclone Drug Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Eszopiclone Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Eszopiclone Drug by Application (2019-2030)
Figure 59. Global Eszopiclone Drug Price (USD/Unit) by Application (2019-2030)
Figure 60. Eszopiclone Drug Value Chain
Figure 61. Eszopiclone Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
